BRPI0810858A2 - Derivados de 2-heteroaril-pirrolo[3,4-c] pirrol e seus usos como inibidores de scd - Google Patents
Derivados de 2-heteroaril-pirrolo[3,4-c] pirrol e seus usos como inibidores de scdInfo
- Publication number
- BRPI0810858A2 BRPI0810858A2 BRPI0810858-7A2A BRPI0810858A BRPI0810858A2 BR PI0810858 A2 BRPI0810858 A2 BR PI0810858A2 BR PI0810858 A BRPI0810858 A BR PI0810858A BR PI0810858 A2 BRPI0810858 A2 BR PI0810858A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrollo
- heteroaryl
- scd inhibitors
- pirrol
- derivatives
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical class C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07008646 | 2007-04-27 | ||
| PCT/EP2008/003019 WO2008135141A1 (de) | 2007-04-27 | 2008-04-16 | 2 -heteroaryl- pyrrolo [3, 4-c] pyrrol- derivate und deren verwendung als scd inhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0810858A2 true BRPI0810858A2 (pt) | 2014-10-29 |
Family
ID=38473076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0810858-7A2A BRPI0810858A2 (pt) | 2007-04-27 | 2008-04-16 | Derivados de 2-heteroaril-pirrolo[3,4-c] pirrol e seus usos como inibidores de scd |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8003677B2 (pt) |
| EP (1) | EP2152711B1 (pt) |
| JP (1) | JP2010524987A (pt) |
| KR (1) | KR20100015975A (pt) |
| CN (1) | CN101663306A (pt) |
| AR (1) | AR066290A1 (pt) |
| AT (1) | ATE489389T1 (pt) |
| AU (1) | AU2008248996A1 (pt) |
| BR (1) | BRPI0810858A2 (pt) |
| CA (1) | CA2685543A1 (pt) |
| CL (1) | CL2008001215A1 (pt) |
| DE (1) | DE502008001903D1 (pt) |
| IL (1) | IL201764A0 (pt) |
| MX (1) | MX2009011112A (pt) |
| TW (1) | TW200911809A (pt) |
| UY (1) | UY31053A1 (pt) |
| WO (1) | WO2008135141A1 (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010028761A1 (de) * | 2008-09-09 | 2010-03-18 | Sanofi-Aventis | 2-heteroaryl-pyrrolo[3, 4-c]pyrrol-derivate und ihre verwendung als scd inhibitoren |
| WO2010108268A1 (en) * | 2009-03-23 | 2010-09-30 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| BR112012016733A2 (pt) | 2010-01-07 | 2015-09-01 | Du Pont | "composto, composição fungicida e método" |
| CN102260265B (zh) * | 2010-05-24 | 2015-09-02 | 上海阳帆医药科技有限公司 | 六氢吡咯[3,4-b]吡咯衍生物、其制备方法及其用途 |
| RU2013114390A (ru) | 2010-08-31 | 2014-10-10 | СНУ Ар энд ДиБи ФАУНДЕЙШН | Применение фетального репрограммирования посредством ppar-дельта-агониста |
| US8501768B2 (en) * | 2011-05-17 | 2013-08-06 | Hoffmann-La Roche Inc. | Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds |
| WO2013056148A2 (en) | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Methods of using scd1 antagonists |
| IN2014DN09346A (pt) | 2012-06-13 | 2015-07-17 | Hoffmann La Roche | |
| KR102179599B1 (ko) | 2012-09-25 | 2020-11-19 | 에프. 호프만-라 로슈 아게 | 이환형 유도체 |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| CN105764905B (zh) | 2013-11-26 | 2019-06-07 | 豪夫迈·罗氏有限公司 | 新的八氢-环丁二烯并[1，2-c；3，4-c’]二吡咯-2基 |
| CN106103446B (zh) | 2014-03-26 | 2019-07-30 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物 |
| WO2015144609A1 (en) | 2014-03-26 | 2015-10-01 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| WO2016046837A1 (en) | 2014-09-22 | 2016-03-31 | Cadila Healthcare Limited | An improved process for preparation of pyrrolo[3,4- c] pyrrole compounds and intermediates thereof |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| CA2992889A1 (en) | 2015-09-04 | 2017-03-09 | F. Hoffmann-La Roche Ag | Phenoxymethyl derivatives |
| RU2018112230A (ru) * | 2015-09-24 | 2019-10-30 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов atx |
| CR20180057A (es) * | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca. |
| AU2016328365B2 (en) | 2015-09-24 | 2020-04-23 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| KR20180054830A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 오토탁신(atx) 억제제로서의 이환형 화합물 |
| CN108299437B (zh) * | 2017-01-13 | 2022-07-08 | 广东东阳光药业有限公司 | 八氢吡咯并[3,4-c]吡咯衍生物及其用途 |
| SG11201908560SA (en) | 2017-03-16 | 2019-10-30 | Hoffmann La Roche | Heterocyclic compounds useful as dual atx/ca inhibitors |
| WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
| ES2747768T3 (es) | 2017-03-20 | 2020-03-11 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de quinasa de piruvato (PKR) |
| US12053458B2 (en) | 2018-09-19 | 2024-08-06 | Novo Nordisk Health Care Ag | Treating sickle cell disease with a pyruvate kinase R activating compound |
| ES2989438T3 (es) | 2018-09-19 | 2024-11-26 | Novo Nordisk Healthcare Ag | Activación de la piruvato cinasa R |
| US20220378756A1 (en) | 2019-09-19 | 2022-12-01 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| EP4622958A1 (en) | 2022-11-21 | 2025-10-01 | Novo Nordisk Health Care AG | Synthesis of pyrrolo[3,4-c]pyrroles |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2580857A1 (en) * | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| EP2289510A1 (en) * | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
-
2008
- 2008-04-16 AU AU2008248996A patent/AU2008248996A1/en not_active Abandoned
- 2008-04-16 KR KR1020097022497A patent/KR20100015975A/ko not_active Withdrawn
- 2008-04-16 BR BRPI0810858-7A2A patent/BRPI0810858A2/pt not_active Application Discontinuation
- 2008-04-16 WO PCT/EP2008/003019 patent/WO2008135141A1/de not_active Ceased
- 2008-04-16 CA CA002685543A patent/CA2685543A1/en not_active Abandoned
- 2008-04-16 DE DE502008001903T patent/DE502008001903D1/de active Active
- 2008-04-16 MX MX2009011112A patent/MX2009011112A/es not_active Application Discontinuation
- 2008-04-16 AT AT08735269T patent/ATE489389T1/de active
- 2008-04-16 EP EP08735269A patent/EP2152711B1/de not_active Not-in-force
- 2008-04-16 CN CN200880012991A patent/CN101663306A/zh active Pending
- 2008-04-16 JP JP2010504505A patent/JP2010524987A/ja not_active Withdrawn
- 2008-04-24 TW TW097114960A patent/TW200911809A/zh unknown
- 2008-04-24 AR ARP080101740A patent/AR066290A1/es unknown
- 2008-04-25 UY UY31053A patent/UY31053A1/es not_active Application Discontinuation
- 2008-04-25 CL CL200801215A patent/CL2008001215A1/es unknown
-
2009
- 2009-10-26 US US12/605,631 patent/US8003677B2/en not_active Expired - Fee Related
- 2009-10-26 IL IL201764A patent/IL201764A0/en unknown
-
2011
- 2011-06-15 US US13/160,705 patent/US20110245263A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR066290A1 (es) | 2009-08-12 |
| MX2009011112A (es) | 2009-10-28 |
| WO2008135141A1 (de) | 2008-11-13 |
| IL201764A0 (en) | 2010-06-16 |
| DE502008001903D1 (de) | 2011-01-05 |
| EP2152711A1 (de) | 2010-02-17 |
| EP2152711B1 (de) | 2010-11-24 |
| UY31053A1 (es) | 2008-11-28 |
| US20100144594A1 (en) | 2010-06-10 |
| AU2008248996A1 (en) | 2008-11-13 |
| TW200911809A (en) | 2009-03-16 |
| CN101663306A (zh) | 2010-03-03 |
| CL2008001215A1 (es) | 2008-09-22 |
| US8003677B2 (en) | 2011-08-23 |
| CA2685543A1 (en) | 2008-11-13 |
| JP2010524987A (ja) | 2010-07-22 |
| KR20100015975A (ko) | 2010-02-12 |
| ATE489389T1 (de) | 2010-12-15 |
| US20110245263A1 (en) | 2011-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0810858A2 (pt) | Derivados de 2-heteroaril-pirrolo[3,4-c] pirrol e seus usos como inibidores de scd | |
| BRPI0719166A2 (pt) | Derivados de espiro-oxindol tricíclicos e seus usos como agentes terapêuticos | |
| BR112012001061A2 (pt) | glicosídeos 2,3-fluorados como inibidores de neuraminidase e seu uso como antivirais | |
| BRPI0909185A2 (pt) | Derivado de vitamina e e seus usos | |
| BRPI0807346A2 (pt) | derivados de 3-amino-pirrolo[3,4-c]pirazol-5(1h,4h,6h)carbaldeído como inibidores de pkc | |
| BR112012000370A2 (pt) | derivados de 1,2,4-tiazolidin-3-ona e seus usos no tratamento de câncer | |
| BRPI0908225A2 (pt) | derivados de piridazina e seu uso como agentes terapêuticos | |
| BRPI0817881A2 (pt) | Compostos orgânicos e seus usos | |
| BRPI0810679A2 (pt) | Derivados de 4-aza indol e seu uso como fungicidas | |
| BRPI1016150A2 (pt) | compostos heterocíclicos e seus usos. | |
| BRPI0919738A2 (pt) | 3h-imidazo[4,5-c] piridino-6-carboxamidas como agentes anti-inflamatórios | |
| BR112012029437A2 (pt) | derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk | |
| BRPI0908433A2 (pt) | pirrolo[2,3-d]piridinas e empregos destas como inibidores tirosina cinase | |
| BRPI0720383A2 (pt) | Derivados de 4-imidazolil-1,2,3,4-tetraidroquinolila e seu emprego como inibidores de aldosterona/11-beta-hidroxilase | |
| BRPI0910746A2 (pt) | reticuladores e seus usos | |
| BRPI0921862A2 (pt) | inibidores de raf e seus usos | |
| BRPI0918841A2 (pt) | derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol, seus cristais e composições farmacêuticas | |
| BRPI1012697A2 (pt) | derivados imidazo[1,2-a]piridina substituídos, composições farmacêuticas, e métodos de uso como inibidores da b-secretase | |
| BRPI0722088A2 (pt) | derivados de pirrolo[2,3-b]piridina como moduladores de cinase | |
| BRPI1010239A2 (pt) | endoglucanases aprimoradas, derivados e seus usos | |
| BRPI0913885A2 (pt) | Tiadiazoliloxifenilamidinas e seus uso como fungicidas | |
| DK2229391T3 (da) | Pyrido[2,3-B]pyrazin-8-substituerede forbindelser og deres anvendelse | |
| BRPI1009118A2 (pt) | 3h-imidazo[4,5-c] piridina-6-carboxamidas como agentes anti-inflamatórios | |
| BRPI0710878A2 (pt) | Compostos orgânicos e seus usos | |
| BRPI1008045A2 (pt) | derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |